Validation and application of a method for the determination of nicotine and five major metabolites in smokers' urine by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
about
Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse modelQuantitation of cotinine and its metabolites in rat plasma and brain tissue by hydrophilic interaction chromatography tandem mass spectrometry (HILIC-MS/MS).Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectSimultaneous determination of cotinine and trans-3-hydroxycotinine in urine by automated solid-phase extraction using gas chromatography-mass spectrometry.Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.Analysis of [3',3'-d(2)]-nicotine and [3',3'-d(2)]-cotinine by capillary liquid chromatography-electrospray tandem mass spectrometry.Quantitative determination of total methamphetamine and active metabolites in rat tissue by liquid chromatography with tandem mass spectrometric detection.Liquid chromatography tandem mass spectrometry in the clinical laboratory.Simple and rapid assay method for simultaneous quantification of urinary nicotine and cotinine using micro-extraction by packed sorbent and gas chromatography-mass spectrometry.Simultaneous quantification of tobacco alkaloids and major phase I metabolites by LC-MS/MS in human tissue.Simultaneous quantitation of urinary cotinine and acrylonitrile-derived mercapturic acids with ultraperformance liquid chromatography-tandem mass spectrometry.
P2860
Q33613568-E5202D98-7FEF-4ACF-86C0-1BAA5C0373CEQ33637189-8D3C6A1A-F5FD-422B-878A-119846B9DFE9Q33909660-D100CAA8-2673-4A09-B439-EBB29B7EA8F2Q34286978-81060CD0-3B60-4233-9EF0-ECC2F78049B1Q35041035-0C5A2291-6320-4CE3-A090-7A1632D3E761Q35099123-7542C3D0-2CFC-4933-9721-7C9EB70098EFQ36445771-88DDB753-E303-42DC-A383-DAB457F37B64Q37361851-113C7984-22C3-40FC-A300-B2B94B7C0485Q38260022-6E327508-F3CC-4124-A356-AA3EB59B9218Q42108167-0D0682DA-D0D2-434D-A2B0-5A7595CAD974Q48489886-7A324313-A873-4EF7-9868-3C662E246311Q53137785-E49C61BB-6E3D-41B0-A7AF-CE9376A2F3BA
P2860
Validation and application of a method for the determination of nicotine and five major metabolites in smokers' urine by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Validation and application of ...... aphy-tandem mass spectrometry.
@ast
Validation and application of ...... aphy-tandem mass spectrometry.
@en
type
label
Validation and application of ...... aphy-tandem mass spectrometry.
@ast
Validation and application of ...... aphy-tandem mass spectrometry.
@en
prefLabel
Validation and application of ...... aphy-tandem mass spectrometry.
@ast
Validation and application of ...... aphy-tandem mass spectrometry.
@en
P2093
P2860
P356
P1476
Validation and application of ...... aphy-tandem mass spectrometry.
@en
P2093
David L Heavner
Joel D Richardson
Michael W Ogden
Walter T Morgan
P2860
P304
P356
10.1002/BMC.463
P577
2005-05-01T00:00:00Z